This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Discover what defines a good retirement plan. Tailor your approach to fit your goals and create a secure financial future for yourself.
19,445 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Can Netflix grow from its current scale to a trillion-dollar market value? This article breaks down the unlikely path...
Investors are weighing Alibaba's prospects after a tough stretch. This guide examines whether alibaba stock rebound c...
Across a century and a half, Western Union has defined cross-border payments. Yet fintech competition and shifting co...
SpaceX pursues space-based AI data centers ahead of a 2026 IPO, stirring talk of a market shakeout as investors weigh...
A quiet crisis is forming in the real estate lending world. This article explains the $3 trillion challenge, who feel...
A high-profile ethics allegation shines a light on how disaster-relief money can intersect with politics and personal...
BioCryst faces a pivotal year. This practical guide breaks down what biocryst (bcrx) 2026 earnings could mean for inv...
A major fund reportedly dumped million in Netskope stock after the cloud-security name sank about half from its IPO l...
Savers are rethinking cash holdings as rates rise. Here are three higher-yield alternatives traditional savings that ...
The Nasdaq led a tech-led rally as AI demand and solid jobs data improved sentiment. This analysis breaks down what m...
Authorities have begun evacuations from a hantavirus-hit cruise, with American passengers slated for quarantine in Ne...